JP2024503718A5 - - Google Patents
Info
- Publication number
- JP2024503718A5 JP2024503718A5 JP2023543203A JP2023543203A JP2024503718A5 JP 2024503718 A5 JP2024503718 A5 JP 2024503718A5 JP 2023543203 A JP2023543203 A JP 2023543203A JP 2023543203 A JP2023543203 A JP 2023543203A JP 2024503718 A5 JP2024503718 A5 JP 2024503718A5
- Authority
- JP
- Japan
- Prior art keywords
- breast cancer
- positive
- negative
- cdk4
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/151,108 | 2021-01-15 | ||
| US17/151,108 US20210228529A1 (en) | 2012-07-13 | 2021-01-15 | Pharmaceutical compositions for treating breast cancers and methods of uses thereof |
| PCT/US2022/012631 WO2022155543A1 (en) | 2021-01-15 | 2022-01-14 | Pharmaceutical compositions for treating breast cancers and methods of uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024503718A JP2024503718A (ja) | 2024-01-26 |
| JP2024503718A5 true JP2024503718A5 (https=) | 2025-01-21 |
Family
ID=82448697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023543203A Pending JP2024503718A (ja) | 2021-01-15 | 2022-01-14 | 乳がんを治療するための薬学的組成物及びその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4277613A4 (https=) |
| JP (1) | JP2024503718A (https=) |
| KR (1) | KR20230163362A (https=) |
| CN (1) | CN116981451A (https=) |
| AU (1) | AU2022208712A1 (https=) |
| BR (1) | BR112023014247A2 (https=) |
| CA (1) | CA3205212A1 (https=) |
| IL (1) | IL304467A (https=) |
| MX (1) | MX2023008375A (https=) |
| WO (1) | WO2022155543A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115369089A (zh) * | 2022-08-11 | 2022-11-22 | 中山大学孙逸仙纪念医院 | 两种er阳性her-2阴性乳腺癌cdk4/6抑制剂耐药株及其构建方法和用途 |
| CN117982655B (zh) * | 2023-11-21 | 2024-10-15 | 北京大学人民医院 | 芳香化酶抑制剂治疗相关的疼痛动物模型构建方法及应用 |
| WO2025208260A1 (zh) * | 2024-04-01 | 2025-10-09 | 北京脑科学与类脑研究所 | 丙酰胺类雄激素受体拮抗剂及其制备方法和用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20040818A2 (en) * | 2002-02-28 | 2005-02-28 | University Of Tennessee Research Foundation | Haloacetamide and azide substituted compounds and methods of use thereof |
| JP2009506119A (ja) * | 2005-08-31 | 2009-02-12 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | 選択的アンドロゲン受容体モジュレーターを用いる腎疾患、熱傷、創傷および脊髄損傷の処置 |
| LT2872482T (lt) * | 2012-07-13 | 2020-12-28 | Oncternal Therapeutics, Inc. | Krūties vėžių gydymo būdas selektyviu androgeno receptoriaus moduliatoriumi |
| US10987334B2 (en) * | 2012-07-13 | 2021-04-27 | University Of Tennessee Research Foundation | Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs) |
| US10258596B2 (en) * | 2012-07-13 | 2019-04-16 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
| US10314807B2 (en) * | 2012-07-13 | 2019-06-11 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
| KR101709601B1 (ko) * | 2016-05-30 | 2017-02-23 | 주식회사 에스앤지바이오텍 | 고정부가 형성된 가이드부재를 포함하는 스텐트 삽입장치 |
| MX389702B (es) * | 2016-06-22 | 2025-03-20 | Ellipses Pharma Ltd | Compuestos para usarse en el tratamiento de cancer de mama que expresa el receptor de androgenos (ar+). |
| WO2020028593A1 (en) * | 2018-07-31 | 2020-02-06 | Oncternal Therapeutics, Inc. | A method of treating er mutant expressing breast cancers with selective androgen receptor modulators (sarms) |
| WO2020206035A1 (en) * | 2019-04-01 | 2020-10-08 | G1 Therapeutics, Inc. | Treatment of cdk4/6 inhibitor resistant neoplastic disorders |
-
2022
- 2022-01-14 WO PCT/US2022/012631 patent/WO2022155543A1/en not_active Ceased
- 2022-01-14 MX MX2023008375A patent/MX2023008375A/es unknown
- 2022-01-14 CA CA3205212A patent/CA3205212A1/en active Pending
- 2022-01-14 EP EP22740195.7A patent/EP4277613A4/en active Pending
- 2022-01-14 KR KR1020237027185A patent/KR20230163362A/ko active Pending
- 2022-01-14 AU AU2022208712A patent/AU2022208712A1/en active Pending
- 2022-01-14 JP JP2023543203A patent/JP2024503718A/ja active Pending
- 2022-01-14 BR BR112023014247A patent/BR112023014247A2/pt unknown
- 2022-01-14 CN CN202280021307.2A patent/CN116981451A/zh active Pending
-
2023
- 2023-07-13 IL IL304467A patent/IL304467A/en unknown